Arkstone Unveils NeoSure™: Enhancing Maternal Health Safety

Arkstone Launches NeoSure™ for Enhanced Maternal Health

Arkstone, a prominent leader in laboratory infectious disease guidance and antimicrobial stewardship, is excited to announce the rollout of NeoSure™. This innovative addition to the OneChoice platform introduces a critical focus on breastfeeding safety alongside existing pregnancy treatment guidance. Healthcare providers will now have access to even more comprehensive antimicrobial safety recommendations for both pregnant and nursing mothers.

Understanding the Significance of NeoSure™

Managing antimicrobial treatment during pregnancy and breastfeeding can be quite challenging. Certain medications might pose risks for fetal development and can also be transmitted through breast milk, potentially impacting infant health. OneChoice has already successfully provided AI-enhanced pregnancy treatment guidance. With the introduction of NeoSure™, the platform now extends its expertise to encompass breastfeeding safety, ensuring a higher level of precision in maternal care.

Expert Insights on NeoSure™

Dr. Ari Frenkel, the Chief Science Officer at Arkstone, expressed enthusiasm about the benefits of NeoSure™: "With NeoSure™, we're expanding our commitment to maternal and infant safety. OneChoice previously supported clinicians in safe prescribing during pregnancy. Now, the inclusion of breastfeeding data makes this solution even more comprehensive—offering clarity where uncertainty once existed." This statement highlights the dual focus of NeoSure™ on both maternal and infant health.

A Comprehensive Look at NeoSure™ Features

The launch of NeoSure™ transforms OneChoice reports, delivering heightened patient-specific treatment guidance by incorporating crucial data on both pregnancy and breastfeeding safety. Key features include:

• Expanded Maternal Care Framework: While OneChoice has long accounted for pregnancy status in antimicrobial recommendations, NeoSure™ augments this capability by integrating insights on breastfeeding safety, rounding out an all-encompassing maternal care solution.
• Seamless Lab & Clinician Collaboration: Laboratories can now include details regarding pregnancy and breastfeeding status when submitting patient data. Clinicians using OneChoice Plus can also update this information for immediate adjustments, making it easier for specialists to provide tailored care.
• Minimized Infant Risk: By enabling providers to adjust medication selection and breastfeeding schedules carefully, NeoSure™ helps decrease unnecessary infant exposure while maintaining effective treatments for mothers.

According to Dave Gross, Chief Technology Officer at Arkstone, "NeoSure™ enhances OneChoice's capabilities through Arkstone's Antimicrobial Intelligence framework, ensuring clinicians receive the most precise, evidence-based recommendations available. By integrating breastfeeding safety, we are giving providers the confidence to prescribe with precision, protecting both mother and child." This commitment to accuracy is crucial in delivering safe treatments in maternal care.

The Importance of Antimicrobial Stewardship

NeoSure™ reflects Arkstone's ongoing dedication to promoting antimicrobial stewardship through precision-guided medicine. By elevating OneChoice's maternal care capabilities, Arkstone guarantees that every prescription accounts for both pregnancy and breastfeeding safety. This comprehensive approach assists healthcare providers in making the most informed decisions that protect the health of both mother and baby.

About Arkstone

As a global leader in infectious disease clinical guidance and antimicrobial stewardship, Arkstone leverages AI-enhanced solutions to provide evidence-based, patient-specific recommendations that combat antibiotic misuse and antimicrobial resistance. Their goal is to ensure smarter prescribing decisions worldwide, creating safer health outcomes.

For further details, you can visit www.arkstone.ai or contact via email.

Frequently Asked Questions

What is NeoSure™?

NeoSure™ is Arkstone's latest addition to its OneChoice platform, focusing on integrating breastfeeding safety into antimicrobial recommendations for mothers.

How does NeoSure™ enhance maternal care?

It expands the capabilities of OneChoice by providing specific guidance for breastfeeding safety, in addition to pregnancy treatment recommendations.

Why is breastfeeding safety important in maternal health?

Breastfeeding safety is crucial because certain medications can pass through breast milk, potentially affecting infant health. NeoSure™ addresses these concerns effectively.

What are the key features of NeoSure™?

Key features include an expanded maternal care framework, seamless input from laboratories and clinicians, and a system to minimize infant risk.

How can I learn more about Arkstone?

For more information about Arkstone and its solutions, visit their website or contact them directly through their official channels.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.